EBOS Group Limited (NZE:EBO)

Market Cap	8.33B
Revenue (ttm)	13.92B
Net Income (ttm)	271.67M
Shares Out	203.23M
EPS (ttm)	1.40
PE Ratio	29.16
Forward PE	25.85
Dividend	1.24 (3.04%)
Ex-Dividend Date	Feb 27, 2025

Volume	27,815
Average Volume	113,202
Open	40.96
Previous Close	40.97
Day's Range	40.82 - 41.50
52-Week Range	34.75 - 42.55
Beta	0.25
RSI	58.91
Earnings Date	Aug 27, 2025

About Accolade

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1922
• Employees: 4,963
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: EBO

Financial Performance

In 2024, EBOS Group's revenue was 13.19 billion, an increase of 7.78% compared to the previous year's 12.24 billion. Earnings were 271.55 million, an increase of 7.17%.